Belgian biotech firms among European market leaders

Belgium has climbed to second place in the European biotech industry, after Denmark, according to data released by KBC Securities on Wednesday. At the end of March 2023, Belgian companies in the sector had capitalised a total of 40.1 billion euros, the financial firm reported.

Despite last year's global market downturn, Belgium's life sciences ecosystem remained resilient thanks to the "solid performance" of Ghent biotech company argenx and private biotech companies backed by venture capital. The market value of argenx has risen by almost 25 per cent in less than a year.

However, the situation for small biotech companies capitalised at less than 1 billion euros is more precarious. With a total market value of 1.6 billion euros, Belgium has fallen from fourth to seventh place in the European ranking. Economic and geopolitical uncertainties have put stock market valuations under pressure, affecting IPOs and follow-on offerings, KBC Securities says.

Artificial intelligence

It has nevertheless observed an increase in mergers and acquisitions on the market, which it expects to stimulate investor appetite for the life sciences sector. International venture capitalists and pharmaceutical companies remain very interested in the life sciences sector in Belgium, as shown by recent financing deals.

The biotech ecosystem is experiencing an unprecedented wave of innovation, driven by artificial intelligence, which is increasingly being integrated into the pharmaceutical and healthcare industries, as well as recent advances with regard to Alzheimer's disease.



Relared news

Website preview
Belgian biotech still in European Top-3
Belgium remains a frontrunner in the European biotech landscape. Big companies are doing well, smaller ones have a harder time finding investors.
Website preview
Record number of European patent applications from Belgium
Belgian companies, universities and research institutions submitted a record 2,604 patent applications to the European Patent Office (EPO) in 2022. This represents a 5 per cent increase over the previous year, despite global uncertainties, the EPO Patent Index revealed on Tuesday.
Website preview
Campaign promotes Belgium as a country of innovation
"Embracing openness" is the slogan of a new international campaign launched by prime minister Alexander De Croo on Wednesday to market Belgium abroad.
Website preview
Foreign minister highlights Belgian biopharma during US visit
During a visit to Boston on Thursday, Belgian Foreign minister Hadja Lahbib highlighted Belgian strengths in the pharma and healthcare industry. Several Belgian companies were present in the Massachusetts capital. Lahbib visited the city's Mass Life Sciences Center, the incubator Labcentral 238 and the Dana-Farber Cancer Institute.

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.


Belga News Agency delivers dependable, rapid and high-quality information 24 hours a day, 7 days a week, from Belgium and abroad to all Belgian media. The information covers all sectors, from politics, economics and finance to social affairs, sports and culture, not to mention entertainment and lifestyle.

Every day, our journalists and press photographers produce hundreds of photos and news stories, dozens of online information items, plus audio and video bulletins, all in both national languages. Since the end of March 2022 English has been added as a language.

For public institutions, businesses and various organisations that need reliable information, Belga News Agency also offers a comprehensive range of corporate services to meet all their communication needs.


Arduinkaai 29 1000 Brussels